BASTA STEVEN L (President and CEO) exercised options at PHATHOM PHARMACEUTICALS, INC.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 12/2/2025ACC: 0001193125-25-305575
DirectorOfficer· President and CEO
Since Feb 2026
-48.38K
Net shares
Net seller
$755.6K
Total sold
0
Open market trades
0B · 0S
3
Total transactions
90K acquired · 138.38K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+90K
Price / share
—
Trade value
—
% of position
216.2%
11/28/2025
41.63K→131.63K
Common Stock
Direct
Shares
−48.38K
Price / share
$15.62
Trade value
$755.62K
% of position
36.8%
11/28/2025
131.63K→83.25K
Total
Net shares
+41.63K
Net value
-$755.62K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/28/2025 | M · Option Exercise | +90K | — | — | 216.2% | 41.63K | 131.63K |
| Common Stock Direct | 11/28/2025 | F · Tax Withholding | −48.38K | $15.62 | $755.62K | 36.8% | 131.63K | 83.25K |
| Total | +41.63K | -$755.62K | ||||||
Derivative Transactions1
Performance Shares
Direct
Converts to
Common Stock
90K shares
Shares
−90K
Strike price
0
Held after
180K
Exercisable
—
11/28/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Performance Shares Direct | Common Stock90K shares | 11/28/2025 | M · Option Exercise | −90K | 0 | — | 180K |